Met Life Investment Management, LLC Neuronetics, Inc. Transaction History

Met Life Investment Management, LLC

  • $14.7 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$6.22 - $15.54 $62,635 - $156,487
-10,070 Closed
0 $0
Q2 2021

May 17, 2024
BUY
$10.15 - $17.25 $102,210 - $173,707
10,070 New
10,070 $161,000
Q2 2021

Jun 21, 2023
BUY
$10.15 - $17.25 $102,210 - $173,707
10,070 New
10,070 $161,000
Q2 2021

Mar 22, 2023
BUY
$10.15 - $17.25 $102,210 - $173,707
10,070 New
10,070 $161,000
Q2 2021

Aug 16, 2021
BUY
$10.15 - $17.25 $102,210 - $173,707
10,070 New
10,070 $161,000

Others Institutions Holding STIM

# of Institutions
68
Shares Held
18.4M
Call Options Held
200
Put Options Held
3.6K
View Full List

About Neuronetics, Inc.

STIM Quotes by TradingView
  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $49.7M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email